Denali Therapeutics Inc (DNLI)
24.26
-0.16
(-0.68%)
USD |
NASDAQ |
Nov 21, 16:00
24.26
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Enterprise Value: 2.678B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.678B |
| November 19, 2024 | 2.666B |
| November 18, 2024 | 2.643B |
| November 15, 2024 | 2.769B |
| November 14, 2024 | 3.258B |
| November 13, 2024 | 3.428B |
| November 12, 2024 | 3.465B |
| November 11, 2024 | 3.708B |
| November 08, 2024 | 3.675B |
| November 07, 2024 | 3.424B |
| November 06, 2024 | 3.416B |
| November 05, 2024 | 3.143B |
| November 04, 2024 | 3.080B |
| November 01, 2024 | 3.057B |
| October 31, 2024 | 2.900B |
| October 30, 2024 | 3.028B |
| October 29, 2024 | 3.115B |
| October 28, 2024 | 3.159B |
| October 25, 2024 | 2.925B |
| October 24, 2024 | 2.967B |
| October 23, 2024 | 2.915B |
| October 22, 2024 | 2.945B |
| October 21, 2024 | 2.958B |
| October 18, 2024 | 3.132B |
| October 17, 2024 | 3.108B |
| Date | Value |
|---|---|
| October 16, 2024 | 3.142B |
| October 15, 2024 | 3.026B |
| October 14, 2024 | 3.023B |
| October 11, 2024 | 3.191B |
| October 10, 2024 | 2.866B |
| October 09, 2024 | 2.978B |
| October 08, 2024 | 3.008B |
| October 07, 2024 | 2.990B |
| October 04, 2024 | 3.282B |
| October 03, 2024 | 3.223B |
| October 02, 2024 | 3.339B |
| October 01, 2024 | 3.287B |
| September 30, 2024 | 3.354B |
| September 27, 2024 | 3.317B |
| September 26, 2024 | 3.294B |
| September 25, 2024 | 3.256B |
| September 24, 2024 | 3.445B |
| September 23, 2024 | 3.433B |
| September 20, 2024 | 3.529B |
| September 19, 2024 | 3.549B |
| September 18, 2024 | 3.508B |
| September 17, 2024 | 3.496B |
| September 16, 2024 | 3.446B |
| September 13, 2024 | 3.509B |
| September 12, 2024 | 3.107B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.082B
Minimum
Mar 16 2020
10.26B
Maximum
Dec 22 2020
3.216B
Average
2.717B
Median
Dec 29 2022
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.271M |
| Perspective Therapeutics Inc | 150.86M |
| Protalix BioTherapeutics Inc | 97.03M |
| Electromed Inc | 233.19M |
| Armata Pharmaceuticals Inc | 165.88M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -107.19M |
| Total Expenses (Quarterly) | 123.19M |
| EPS Diluted (Quarterly) | -0.63 |
| Earnings Yield | -11.38% |
| Normalized Earnings Yield | -3.999 |